ArticleCureus2025
Diffuse Pulmonary Meningotheliomatosis: An Exceedingly Rare Disease for a Not-So-Rare Pattern.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Symptomatic diffuse pulmonary meningotheliomatosis with persistent diffusing-capacity impairment.Respiratory medicine case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diffuse pulmonary meningotheliomatosis (DPM) is a rare lung disease characterized by the proliferation of meningothelial-like cells within the pulmonary interstitium. It predominantly affects middle-aged women and is often asymptomatic, although mild respiratory symptoms may occur. Chest CT typically shows diffuse and bilateral micronodules, and histology confirms meningothelial-like nodules expressing epithelial membrane antigen (EMA), CD56, and progesterone receptor. We report the case of a 72-year-old woman undergoing breast cancer staging, who was incidentally found to have bilateral pulmonary micronodules. A conventional transbronchial biopsy confirmed DPM, and a brain MRI ruled out meningioma. The patient remains stable without treatment. DPM is often misdiagnosed, with metastatic disease and granulomatous conditions as key differentials. Although biopsy aids diagnosis, correlation with imaging findings is essential. No specific treatment is required, and the prognosis is generally favorable. Further research is needed to refine diagnoses and management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.